Crispr News

• For sickle cell patients, a CRISPR cure could mean infertility - STAT - STAT
  December 6, 2023
• CRISPR's Reach Widens: Enzyme Targets Nearly All Human Genes - Technology Networks
  December 6, 2023
• Siddhartha Mukherjee: CRISPR, AI, and cloning could transform the human race - GZERO Media
  December 5, 2023
• CRISPR (CRSP) to Focus on Next-Generation CAR T Pipeline - Yahoo Finance
  December 5, 2023
• CRISPR (CRSP) to Focus on Next-Generation CAR T Pipeline - Zacks Investment Research
  December 5, 2023
• Eligo Bioscience Raises $30M in Series B Financing to Develop CRISPR-Based Acne Drug - Precision Medicine Online
  December 5, 2023
• CRISPR Therapeutics ventures into autoimmune disorder CAR T development - Pharmaceutical Technology
  December 5, 2023
• CRISPR Reorganizes CAR-T Pipeline Ahead of FDA’s Landmark Decision - BioSpace
  December 5, 2023
• First CRISPR Sickle Cell Patient ‘Reborn’: FDA Approval Expected - Forbes
  December 5, 2023
• New enzyme allows CRISPR technologies to accurately target almost all human genes - Phys.org
  December 5, 2023
• Better Growth Stock: CRISPR Therapeutics vs. Invitae - The Motley Fool
  December 5, 2023
• Viewpoint: Skeptical take on newly-approved CRISPR sickle cell treatment tool - Genetic Literacy Project
  December 5, 2023
• Crispr gene editing technology could transform medicine | FT Tech - Financial Times
  December 5, 2023
• CRISPR Tx cuts cancer programs, expands into autoimmune disease - FierceBiotech
  December 5, 2023
• CRISPR Therapeutics (CRSP) CTX110 and CTX130 provided important proof of concept - StreetInsider.com
  December 4, 2023
• CRISPR Therapeutics Announces Updates to Immuno-Oncology Pipeline and Expansion into Autoimmune Disease - GlobeNewswire
  December 4, 2023
• CRISPR Therapeutics Announces Updates to Immuno-Oncology Pipeline and Expansion into Autoimmune Disease - Yahoo Finance
  December 4, 2023
• New discovery unveils an additional layer of the CRISPR-Cas antiviral defense system - News-Medical.Net
  December 4, 2023
• Pro Research: Wall Street eyes CRISPR Therapeutics' growth By Investing.com - Investing.com
  December 4, 2023
• First approval of a CRISPR-based gene therapy – Exaudi - Exaudi
  December 4, 2023